We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$269B
AUM Growth
+$11B
Cap. Flow
-$7.32B
Cap. Flow %
-2.72%
Top 10 Hldgs %
22.8%
Holding
3,195
New
25
Increased
1,065
Reduced
1,860
Closed
81

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$1.08B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
BA icon
Boeing
BA
+$396M
4
LIN icon
Linde
LIN
+$381M
5
XOM icon
ExxonMobil
XOM
+$319M

Sector Composition

Rank Sector Weight
1 Technology 26.06%
2 Healthcare 13.1%
3 Financials 11.54%
4 Consumer Discretionary 10.68%
5 Industrials 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSAT icon
1626
Globalstar
GSAT
$10.8B
$7.53M ﹤0.01%
432,588
-42,961
-9% -$792K
ADUS icon
1627
Addus HomeCare
ADUS
$2.23B
$7.53M ﹤0.01%
70,483
-706
-1% -$73.7K
STNG icon
1628
Scorpio Tankers
STNG
$3.81B
$7.52M ﹤0.01%
133,568
-15,409
-10% -$843K
THR
1629
DELISTED
Thermon Group Holdings
THR
$7.52M ﹤0.01%
301,816
+66,392
+28% +$1.62M
VSXY
1630
Victoria's Secret
VSXY
$7.83B
$7.47M ﹤0.01%
218,685
-8,070
-4% -$299K
LAZ icon
1631
Lazard
LAZ
$4.31B
$7.45M ﹤0.01%
225,089
-18,242
-7% -$673K
UBS icon
1632
UBS Group
UBS
$176B
$7.43M ﹤0.01%
348,290
+225,651
+184% +$4.71M
PFSI icon
1633
PennyMac Financial
PFSI
$4.02B
$7.38M ﹤0.01%
123,792
-9,844
-7% -$609K
ASPN icon
1634
Aspen Aerogels
ASPN
$518M
$7.37M ﹤0.01%
989,176
+683,098
+223% +$6.79M
TVTX icon
1635
Travere Therapeutics
TVTX
$5.78B
$7.37M ﹤0.01%
327,653
+143,585
+78% +$3.05M
TK icon
1636
Teekay
TK
$985M
$7.35M ﹤0.01%
1,189,023
+566,523
+91% +$3.03M
APPF icon
1637
AppFolio
APPF
$7.04B
$7.35M ﹤0.01%
59,026
+7,244
+14% +$874K
JBSS icon
1638
John B. Sanfilippo & Son
JBSS
$972M
$7.33M ﹤0.01%
75,609
-40,177
-35% -$3.59M
LIVN icon
1639
LivaNova
LIVN
$4.2B
$7.32M ﹤0.01%
168,000
-33,762
-17% -$1.71M
CHPT icon
1640
ChargePoint
CHPT
$161M
$7.32M ﹤0.01%
34,953
-25,066
-42% -$5.46M
IPAR icon
1641
Interparfums
IPAR
$3.94B
$7.31M ﹤0.01%
51,367
-875
-2% -$108K
CPK icon
1642
Chesapeake Utilities
CPK
$3.21B
$7.3M ﹤0.01%
57,068
-749
-1% -$93K
PDFS icon
1643
PDF Solutions
PDFS
$2.07B
$7.3M ﹤0.01%
172,272
+70,796
+70% +$2.48M
LUMN icon
1644
Lumen
LUMN
$6.44B
$7.29M ﹤0.01%
2,751,182
-1,443,837
-34% -$5.83M
RPAY icon
1645
Repay Holdings
RPAY
$327M
$7.29M ﹤0.01%
1,109,757
+52,919
+5% +$436K
CCO icon
1646
Clear Channel Outdoor Holdings
CCO
$1.23B
$7.28M ﹤0.01%
6,067,081
+561,887
+10% +$828K
TMCI icon
1647
Treace Medical Concepts
TMCI
$309M
$7.28M ﹤0.01%
288,973
+22,474
+8% +$528K
CFFN icon
1648
Capitol Federal Financial
CFFN
$1.1B
$7.25M ﹤0.01%
1,077,734
+291,109
+37% +$2.37M
HPP
1649
Hudson Pacific Properties
HPP
$779M
$7.25M ﹤0.01%
155,746
+86,991
+127% +$5.59M
IRBT
1650
DELISTED
iRobot
IRBT
$7.23M ﹤0.01%
165,732
+5,235
+3% +$232K

Similar funds

Nuveen's Q1 2023 Portfolio in Review

As of Q1 2023, Nuveen held 3,195 positions worth $269B, up 4.3% from $258B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 3.3%. Nuveen opened 25 new positions and exited 81, leaving the 3,195-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q1 2023 buy was GE HealthCare: 1,240,905 shares worth $102M.
  • Nuveen added most to Meta Platforms (Facebook) in Q1 2023, an estimated $1.08B increase.
  • Nuveen's biggest Q1 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.4B.
  • Nuveen fully exited SVB Financial Group in Q1 2023, selling an estimated $51.6M.
  • Nuveen's ten largest holdings make up 23% of its $269B portfolio in Q1 2023.
  • Nuveen opened 25 new positions and closed 81 in Q1 2023.
  • Nuveen's portfolio value rose 4.3% quarter-over-quarter to $269B.

Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.